The World Health Organization (WHO) accepted, on Saturday, a recommendation by one of its medical committees to discontinue the use of the drugs hydroxychloroquine and Robinavir / ritonavir for the treatment of patients with the emerging coronavirus.
In a press release on its official website, the organization indicated that it had launched a medical experiment to find an effective treatment for patients hospitalized.
WHO Press Release: WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
The recommendation was formulated by the International Steering Committee in the light of the evidence on the two drugs, based on the interim results of the experiment.
This came after reviewing evidence from all the experiences presented at the WHO Summit on Research and Innovations held from 1 to 2 July.
The results showed that the two drugs had little or no effect on the virus.
The trials did not show strong evidence of their efficacy, and some safety indications were reported to be published in a leaflet after being reviewed by counterparts.
This decision applies only to conducting the experience of the WHO committee in patients who have been hospitalized and does not affect the potential evaluation in other studies of the two drugs.
